From innovation to application: Social-ecological context, diagnostics, drugs and integrated control of schistosomiasis

Acta Tropica

Volumn 120, Issue SUPPL. 1, 2011, Pages

  Utzinger, Jürg ^a,b   N'Goran, Eliézer K ^c,d   Caffrey, Conor R ^e   Keiser, Jennifer ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^d CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Burden; Diagnosis; Distribution; Drugs; Epidemiology; Integrated control; Population statistics; Schistosomiasis; Social ecological systems

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTISCHISTOSOMAL AGENT; ANTRODIA CAMPHORATA POLYSACCHARIDE; ARACHIDONIC ACID; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; BICALUTAMIDE; CURCUMIN; FLUTAMIDE; MEFLOQUINE; METAKELFIN; NILUTAMIDE; PRAZIQUANTEL; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFALENE; UNCLASSIFIED DRUG;

DISEASE CONTROL; DISEASE SPREAD; DISEASE TRANSMISSION; DRUG; ECOLOGICAL IMPACT; EPIDEMIOLOGY; HEALTH RISK; HUMAN BEHAVIOR; INNOVATION; PUBLIC HEALTH; RESEARCH AND DEVELOPMENT; SCHISTOSOMIASIS;

ABDOMINAL PAIN; ANTRODIA CAMPHORATA; CHILL; COUGHING; DIAGNOSTIC ACCURACY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ECOLOGY; ENDEMIC DISEASE; FECES ANALYSIS; FLOTAC TECHNIQUE; HUMAN; INFECTION RISK; KATO KATZ TECHNIQUE; MALARIA; MALARIA FALCIPARUM; METABOLOMICS; NONHUMAN; PARASITE CONTROL; PARASITE EXAMINATION; POLYMERASE CHAIN REACTION; POVERTY; PREDICTIVE VALUE; PREVALENCE; PROSTATE CANCER; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SINGLE DRUG DOSE; SOCIAL ASPECT; TREMATODE LIFE CYCLE STAGE; VERTIGO; VOMITING;

ANIMALS; ANTHELMINTICS; COMMUNICABLE DISEASE CONTROL; DELIVERY OF HEALTH CARE, INTEGRATED; ECOSYSTEM; HUMANS; PUBLIC HEALTH; SCHISTOSOMIASIS; SOCIAL ENVIRONMENT; TROPICAL CLIMATE;

GASTROPODA;

EID: 79961172802     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.08.020     Document Type: Review

References (226)

1. Aagaard-Hansen J., Mwanga J.R., Bruun B. Social science perspectives on schistosomiasis control in Africa: past trends and future directions. Parasitology 2009, 136:1747-1758.
2. Abdel-Wahab M.F., Strickland G.T., El-Sahly A., El-Kady N., Zakaria S., Ahmed L. Changing pattern of schistosomiasis in Egypt 1935-79. Lancet 1979, 314:242-244.
3. Abdulla M.H., Lim K.C., Sajid M., McKerrow J.H., Caffrey C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med. 2007, 4:e14.
4. Abdulla M.H., Ruelas D.S., Wolff B., Snedecor J., Lim K.C., Xu F.Y., Renslo A.R., Williams J., McKerrow J.H., Caffrey C.R. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl. Trop. Dis. 2009, 3:e478.
5. Adam I., Elhardello O.A., Elhadi M.O., Abdalla E., Elmardi K.A., Jansen F.H. The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria. Ann. Trop. Med. Parasitol. 2009, 103:1062-1064.
6. Alarcón de Noya B., Ruiz R., Losada S., Colmenares C., Contreras R., Cesari I.M., Noya O. Detection of schistosomiasis cases in low-transmission areas based on coprologic and serologic criteria: the Venezuelan experience. Acta Trop. 2007, 103:41-49.
7. Allam G. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology 2009, 214:712-727.
8. Amerasinghe F.P. Irrigation and mosquito-borne diseases. J. Parasitol. 2003, 89(Suppl.):S14-S22.
9. Ayele B., Erko B., Legesse M., Hailu A., Medhin G. Evaluation of circulating cathodic antigen (CCA) strip for diagnosis of urinary schistosomiasis in Hassoba school children, Afar, Ethiopia. Parasite 2008, 15:69-75.
10. Baker M.C., Mathieu E., Fleming F.M., Deming M., King J.D., Garba A., Koroma J.B., Bockarie M., Kabore A., Sankara D.P., Molyneux D.H. Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework. Lancet 2010, 375:231-238.
11. Balen J., Zhao Z.Y., Williams G.M., McManus D.P., Raso G., Utzinger J., Zhou J., Li Y.S. Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China. Bull. World Health Organ. 2007, 85:519-526.
12. Bergquist N.R., Leonardo L.R., Mitchell G.F. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?. Trends Parasitol. 2005, 21:112-117.
13. Bergquist R., Johansen M.V., Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 2009, 25:151-156.
14. Bergquist R., Lustigman S. Control of important helminthic infections: vaccine development as part of the solution. Adv. Parasitol. 2010, 73:297-326.
15. Bergquist R., Utzinger J., McManus D.P. Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl. Trop. Dis. 2008, 2:e244.
16. Berriman M., Haas B.J., LoVerde P.T., Wilson R.A., Dillon G.P., Cerqueira G.C., Mashiyama S.T., Al-Lazikani B., Andrade L.F., Ashton P.D., Aslett M.A., Bartholomeu D.C., Blandin G., Caffrey C.R., Coghlan A., Coulson R., Day T.A., Delcher A., DeMarco R., Djikeng A., Eyre T., Gamble J.A., Ghedin E., Gu Y., Hertz-Fowler C., Hirai H., Hirai Y., Houston R., Ivens A., Johnston D.A., Lacerda D., Macedo C.D., McVeigh P., Ning Z., Oliveira G., Overington J.P., Parkhill J., Pertea M., Pierce R.J., Protasio A.V., Quail M.A., Rajandream M.A., Rogers J., Sajid M., Salzberg S.L., Stanke M., Tivey A.R., White O., Williams D.L., Wortman J., Wu W., Zamanian M., Zerlotini A., Fraser-Liggett C.M., Barrell B.G., El-Sayed N.M. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358.
17. Bethony J.M., Diemert D.J., Oliveira S.C., Loukas A. Can schistosomiasis really be consigned to history without a vaccine?. Vaccine 2008, 26:3373-3376.
18. Boissier J., Cosledan F., Robert A., Meunier B. In vitro activities of trioxaquines against Schistosoma mansoni. Antimicrob. Agents Chemother. 2009, 53:4903-4906.
19. Booth M., Vounatsou P., N'Goran E.K., Tanner M., Utzinger J. The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d'Ivoire. Parasitology 2003, 127:525-531.
20. Botros S.S., William S., Beadle J.R., Valiaeva N., Hostetler K.Y. Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro. Antimicrob. Agents Chemother. 2009, 53:5284-5287.
21. Boulanger D., Dieng Y., Cisse B., Remoue F., Capuano F., Dieme J.L., Ndiaye T., Sokhna C., Trape J.F., Greenwood B., Simondon F. Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:113-116.
22. Braguine C.G., Costa E.S., Magalhâes L.G., Rodrigues V., da Silva Filho A.A., Bastos J.K., Silva M.L., Cunha W.R., Januario A.H., Pauletti P.M. Schistosomicidal evaluation of Zanthoxylum naranjillo and its isolated compounds against Schistosoma mansoni adult worms. Z. Naturforsch. C. 2009, 64:793-797.
23. Brooker S., Hotez P.J., Bundy D.A.P. The global atlas of helminth infection: mapping the way forward in neglected tropical disease control. PLoS Negl. Trop. Dis. 2010, 4:e779.
24. Brooker S., Kabatereine N.B., Smith J.L., Mupfasoni D., Mwanje M.T., Ndayishimiye O., Lwambo N.J.S., Mbotha D., Karanja P., Mwandawiro C., Muchiri E., Clements A.C.A., Bundy D.A.P., Snow R.W. An updated atlas of human helminth infections: the example of East Africa. Int. J. Health Geogr. 2009, 8:42.
25. Bruun B., Aagaard-Hansen J. The Social Context of Schistosomiasis and its Control: An Introduction and Annotated Bibliography 2008, World Health Organization, Geneva.
26. Bukirwa H., Orton L. Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria. Cochrane Database Syst. Rev. 2005, CD004531.
27. Caffrey C.R. Chemotherapy of schistosomiasis: present and future. Curr. Opin. Chem. Biol. 2007, 11:433-439.
28. Caffrey C.R., Williams D.L., Todd M.H., Nelson D.L., Keiser J., Utzinger J. Chemotherapeutic development strategies for schistosomiasis. Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates 2009, 301-321. Wiley-VCH, Weinheim. P.M. Selzer (Ed.).
29. Chand M.A., Chiodini P.L., Doenhoff M.J. Development of a new assay for the diagnosis of schistosomiasis, using cercarial antigens. Trans. R. Soc. Trop. Med. Hyg. 2010, 104:255-258.
30. Chaturvedi D., Goswami A., Saikia P.P., Barua N.C., Rao P.G. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chem. Soc. Rev. 2010, 39:435-454.
31. Chen Y.J., Cheng P.C., Lin C.N., Liao H.F., Chen Y.Y., Chen C.C., Lee K.M. Polysaccharides from Antrodia camphorata mycelia extracts possess immunomodulatory activity and inhibits infection of Schistosoma mansoni. Int. Immunopharmacol. 2008, 8:458-467.
32. Chitsulo L., Engels D., Montresor A., Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000, 77:41-51.
33. Choudhry A.W. Potential effects of irrigation on the spread of bilharziasis in Kenya. East Afr. Med. J. 1975, 52:120-126.
34. Cioli D. Praziquantel: is there real resistance and are there alternatives?. Curr. Opin. Infect. Dis. 2000, 13:659-663.
35. Cioli D., Botros S.S., Wheatcroft-Francklow K., Mbaye A., Southgate V., Tchuem Tchuenté L.A., Pica-Mattoccia L., Troiani A.R., El-Din S.H., Sabra A.N., Albin J., Engels D., Doenhoff M.J. Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. Int. J. Parasitol. 2004, 34:979-987.
36. Cioli D., Valle C., Angelucci F., Miele A.E. Will new antischistosomal drugs finally emerge?. Trends Parasitol. 2008, 24:379-382.
37. Colley D.G., LoVerde P.T., Savioli L. Medical helminthology in the 21st century. Science 2001, 293:1437-1438.
38. Conceição M.J., Argento C.A., Corrêa A. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine. Mem. Inst. Oswaldo Cruz 2000, 95:375-380.
39. Cox D.D., Todd A.C. Survey of gastrointestinal parasitism in Wisconsin dairy cattle. J. Am. Vet. Med. Assoc. 1962, 141:706-709.
40. Cringoli G. FLOTAC, a novel apparatus for a multivalent faecal egg count technique. Parassitologia 2006, 48:381-384.
41. Cringoli G., Rinaldi L., Maurelli M.P., Utzinger J. FLOTAC: new multivalent techniques for qualitative and quantitative copromicroscopic diagnosis of parasites in animals and humans. Nat. Protoc. 2010, 5:503-515.
42. Danso-Appiah A., Utzinger J., Liu J., Olliaro P. Drugs for treating urinary schistosomiasis. Cochrane Database Syst. Rev. 2008, CD000053.
43. Davis A. Schistosomiasis. Manson's Tropical Diseases 2009, 1425-1460. Saunders Elsevier. G.C. Cook, A.I. Zumla (Eds.).
44. de Oliveira Penido M.L., Zech Coelho P.M., de Mello R.T., Pilo-Veloso D., de Oliveira M.C., Kusel J.R., Nelson D.L. Antischistosomal activity of aminoalkanethiols, aminoalkanethiosulfuric acids and the corresponding disulfides. Acta Trop. 2008, 108:249-255.
45. de Vlas S.J., Gryseels B. Underestimation of Schistosoma mansoni prevalences. Parasitol. Today 1992, 8:274-277.
46. Deelder A.M., De Jonge N., Boerman O.C., Fillie Y.E., Hilberath G.W., Rotmans J.P., Gerritse M.J., Schut D.W. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am. J. Trop. Med. Hyg. 1989, 40:268-272.
47. Doenhoff M.J., Chiodini P.L., Hamilton J.V. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies?. Trends Parasitol. 2004, 20:35-39.
48. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21:659-667.
49. Dong Y., Chollet J., Vargas M., Mansour N.R., Bickle Q., Alnouti Y., Huang J., Keiser J., Vennerstrom J.L. Praziquantel analogs with activity against juvenile Schistosoma mansoni. Bioorg. Med. Chem. Lett. 2010, 20:2481-2484.
50. Ehrenberg J.P., Ault S.K. Neglected diseases of neglected populations: thinking to reshape the determinants of health in Latin America and the Caribbean. BMC Public Health 2005, 5:119.
51. El Ridi R., Aboueldahab M., Tallima H., Salah M., Mahana N., Fawzi S., Mohamed S.H., Fahmy O.M. In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium. Antimicrob. Agents Chemother. 2010, 54:3383-3389.
52. Engels D., Chitsulo L., Montresor A., Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop. 2002, 82:139-146.
53. Engels D., Nahimana S., de Vlas S.J., Gryseels B. Variation in weight of stool samples prepared by the Kato-Katz method and its implications. Trop. Med. Int. Health 1997, 2:265-271.
54. Engels D., Sinzinkayo E., de Vlas S.J., Gryseels B. Intraspecimen fecal egg count variation in Schistosoma mansoni infection. Am. J. Trop. Med. Hyg. 1997, 57:571-577.
55. Engels D., Sinzinkayo E., Gryseels B. Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications. Am. J. Trop. Med. Hyg. 1996, 54:319-324.
56. Enk M.J., Lima A.C., Drummond S.C., Schall V.T., Coelho P.M. The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmission. Acta Trop. 2008, 108:222-228.
57. Fallon P.G., Mubarak J.S., Fookes R.E., Niang M., Butterworth A.E., Sturrock R.F., Doenhoff M.J. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Exp. Parasitol. 1997, 86:29-36.
58. Fenwick A. Waterborne infectious diseases-could they be consigned to history?. Science 2006, 313:1077-1081.
59. Fenwick A., Savioli L., Engels D., Bergquist N.R., Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 2003, 19:509-515.
60. Fenwick A., Webster J.P., Bosque-Oliva E., Blair L., Fleming F.M., Zhang Y., Garba A., Stothard J.R., Gabrielli A.F., Clements A.C.A., Kabatereine N.B., Toure S., Dembele R., Nyandindi U., Mwansa J., Koukounari A. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009, 136:1719-1730.
61. Finkelstein J.L., Schleinitz M.D., Carabin H., McGarvey S.T. Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature. PLoS Negl. Trop. Dis. 2008, 2:e158.
62. Garcia-Perez I., Angulo S., Utzinger J., Holmes E., Legido-Quigley C., Barbas C. Chemometric and biological validation of a capillary electrophoresis metabolomic experiment of Schistosoma mansoni infection in mice. Electrophoresis 2010, 31:2338-2348.
63. Garcia-Perez I., Couto Alves A., Angulo S., Li J.V., Utzinger J., Ebbels T.M.D., Legido-Quigley C., Nicholson J.K., Holmes E., Barbas C. Bidirectional correlation of NMR and capillary electrophoresis fingerprints: a new approach to investigating Schistosoma mansoni infection in a mouse model. Anal. Chem. 2010, 82:203-210.
64. García-Pérez I., Whitfield P., Bartlett A., Angulo S., Legido-Quigley C., Hanna-Brown M., Barbas C. Metabolic fingerprinting of Schistosoma mansoni infection in mice urine with capillary electrophoresis. Electrophoresis 2008, 29:3201-3206.
65. Glinz D., Silué K.D., Knopp S., Lohourignon L.K., Yao P.K., Steinmann P., Rinaldi L., Cringoli G., N'Goran E.K., Utzinger J. Comparing diagnostic accuracy of Kato-Katz, Koga agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PLoS Negl. Trop. Dis. 2010, 4:e754.
66. Gomes L.I., dos Santos Marques L.H., Enk M.J., de Oliveira M.C., Coelho P.M.Z., Rabello A. Development and evaluation of a sensitive PCR-ELISA system for detection of Schistosoma infection in feces. PLoS Negl. Trop. Dis. 2010, 4:e664.
67. Gray D.J., McManus D.P., Li Y.S., Williams G.M., Bergquist R., Ross A.G. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect. Dis. 2010, 10:733-736.
68. Greany W.H. Schistosomiasis in the Gezira irrigated area of the Anglo-Egyption Sudan. I. Public health and field aspects. Ann. Trop. Med. Parasitol. 1952, 46:250-267.
69. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
70. Hamilton J.V., Klinkert M., Doenhoff M.J. Diagnosis of schistosomiasis: antibody detection, with notes on parasitological and antigen detection methods. Parasitology 1998, 117(Suppl.):S41-57.
71. Hatz C.F.R. The use of ultrasound in schistosomiasis. Adv. Parasitol. 2001, 48:225-284.
72. Hillyer G.V., Tsang V.C., Vivas-Gonzalez B.E., Noh J., Ahn L.H., Vorndam V. Age-specific decrease in seroprevalence of schistosomiasis in Puerto Rico. Am. J. Trop. Med. Hyg. 1999, 60:313-318.
73. Holmes E. The evolution of metabolic profiling in parasitology. Parasitology 2010, 137:1437-1449.
74. Holveck J.C., Ehrenberg J.P., Ault S.K., Rojas R., Vasquez J., Cerqueira M.T., Ippolito-Shepherd J., Genovese M.A., Periago M.R. Prevention, control, and elimination of neglected diseases in the Americas: pathways to integrated, inter-programmatic, inter-sectoral action for health and development. BMC Public Health 2007, 7:6.
75. Hotez P.J., Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl. Trop. Dis. 2009, 3:e485.
76. Hotez P.J., Fenwick A., Savioli L., Molyneux D.H. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009, 373:1570-1575.
77. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Ehrlich Sachs S., Sachs J.D., Savioli L. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
78. Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., Sachs J.D. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006, 3:e102.
79. Hotez P.J., Molyneux D.H., Fenwick A., Savioli L., Takeuchi T. A global fund to fight neglected tropical diseases: is the G8 Hokkaido Toyako 2008 summit ready?. PLoS Negl. Trop. Dis. 2008, 2:e220.
80. Huang Y.X., Manderson L. The social and economic context and determinants of schistosomiasis japonica. Acta Trop. 2005, 96:223-231.
81. Hunter J.M., Rey L., Chu K.Y., Adekolu-John E.O., Mott K.E. Parasitic Diseases in Water Resources Development: The Need for Intersectoral Negotiation 1993, World Health Organization, Geneva.
82. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L.F., Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. 1996, 55:214-218.
83. Jacquerioz F.A., Croft A.M. Drugs for preventing malaria in travellers. Cochrane Database Syst. Rev. 2009, CD006491.
84. Jia T.W., Zhou X.N., Wang X.H., Utzinger J., Steinmann P., Wu X.H. Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull. World Health Organ. 2007, 85:458-465.
85. Jobin W. Dams and Disease: Ecological Design and Health Impacts of Large Dams, Canals and Irrigation Systems 1999, E & FN Spon, London and New York.
86. Johansen M.V., Sithithaworn P., Bergquist R., Utzinger J. Towards improved diagnosis of zoonotic trematode infections in Southeast Asia. Adv. Parasitol. 2010, 73:171-195.
87. Jordan P. From Katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia. Acta Trop. 2000, 77:9-40.
88. Kane R.A., Southgate V.R., Rollinson D., Littlewood D.T., Lockyer A.E., Pagès J.R., Tchuem Tchuenté L.A., Jourdane J. A phylogeny based on three mitochondrial genes supports the division of Schistosoma intercalatum into two separate species. Parasitology 2003, 127:131-137.
89. Karbwang J., White N.J. Clinical pharmacokinetics of mefloquine. Clin. Pharmacokinet. 1990, 19:264-279.
90. Kato T., Miura M. On the comparison of some stool examination methods. Jpn. J. Parasitol. 1954, 3:35.
91. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paulo 1972, 14:397-400.
92. Keiser J., Chollet J., Xiao S.H., Mei J.Y., Jiao P.Y., Utzinger J., Tanner M. Mefloquine-an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. 2009, 3:e350.
93. Keiser J., N'Goran E.K., Traore M., Lohourignon K.L., Singer B.H., Lengeler C., Tanner M., Utzinger J. Polyparasitism with Schistosoma mansoni, geohelminths, and intestinal protozoa in rural Côte d'Ivoire. J. Parasitol. 2002, 88:461-466.
94. Keiser J., N'Guessan N.A., Adoubryn K.D., Silue K.D., Vounatsou P., Hatz C., Utzinger J., N'Goran E.K. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin. Infect. Dis. 2010, 50:1205-1213.
95. Keiser J., Utzinger J. Advances in the discovery and development of novel trematocidal drugs. Expert Opin. Drug Discov. 2007, 2(Suppl. 1):S9-23.
96. Keiser J., Utzinger J. Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol. 2007, 23:555-562.
97. Keiser J., Vargas M., Vennerstrom J.L. Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice. J. Antimicrob. Chemother. 2010, 65:1991-1995.
98. King C.H. Parasites and poverty: the case of schistosomiasis. Acta Trop. 2010, 113:95-104.
99. King C.H., Bertino A.M. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl. Trop. Dis. 2008, 2:e209.
100. King C.H., Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008, 4:65-79.
101. King C.H., Dickman K., Tisch D.J. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
102. Knopp S., Rinaldi L., Khamis I.S., Stothard J.R., Rollinson D., Maurelli M.P., Steinmann P., Marti H., Cringoli G., Utzinger J. A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:347-354.
103. Kongs A., Marks G., Verle P., Van der Stuyft P. The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections. Trop. Med. Int. Health 2001, 6:163-169.
104. Krishna S., Bustamante L., Haynes R.K., Staines H.M. Artemisinins: their growing importance in medicine. Trends Pharmacol. Sci. 2008, 29:520-527.
105. Laamrani H., Khallaayoune K., Madsen H., Mahjour J., Gryseels B. New challenges in schistosomiasis control in Morocco. Acta Trop. 2000, 77:61-67.
106. Lambertucci J.R., dos Santos Silva L.C., Andrade L.M., de Queiroz L.C., Carvalho V.T., Voieta I., Antunes C.M. Imaging techniques in the evaluation of morbidity in schistosomiasis mansoni. Acta Trop. 2008, 108:209-217.
107. Legesse M., Erko B. Field-based evaluation of a reagent strip test for diagnosis of Schistosoma mansoni by detecting circulating cathodic antigen in urine before and after chemotherapy. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:668-673.
108. Legesse M., Erko B. Field-based evaluation of a reagent strip test for diagnosis of schistosomiasis mansoni by detecting circulating cathodic antigen (CCA) in urine in low endemic area in Ethiopia. Parasite 2008, 15:151-155.
109. Legido-Quigley C. Metabolite-biomarker investigations in the life cycle of and infection with Schistosoma. Parasitology 2010, 137:1425-1435.
110. Li J.V., Holmes E., Saric J., Keiser J., Dirnhofer S., Utzinger J., Wang Y. Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy. Int. J. Parasitol. 2009, 39:547-558.
111. Li Y.S., Raso G., Zhao Z.Y., He Y.K., Ellis M.K., McManus D.P. Large water management projects and schistosomiasis control, Dongting Lake region, China. Emerg. Infect. Dis. 2007, 13:973-979.
112. Lier T., Simonsen G.S., Wang T., Lu D., Haukland H.H., Vennervald B.J., Hegstad J., Johansen M.V. Real-time polymerase chain reaction for detection of low-intensity Schistosoma japonicum infections in China. Am. J. Trop. Med. Hyg. 2009, 81:428-432.
113. Lin D.D., Liu J.X., Liu Y.M., Hu F., Zhang Y.Y., Xu J.M., Li J.Y., Ji M.J., Bergquist R., Wu G.L., Wu H.W. Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People's Republic of China. Parasitol. Int. 2008, 57:281-286.
114. Lindon J.C., Holmes E., Bollard M.E., Stanley E.G., Nicholson J.K. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004, 9:1-31.
115. Lindon J.C., Holmes E., Nicholson J.K. Metabonomics and its role in drug development and disease diagnosis. Expert Rev. Mol. Diagn. 2004, 4:189-199.
116. Link H., Stohler H.R. 3-Arylhydantoine, eine Substanzklasse mit schistosomizider Wirkung. Eur. J. Med. Chem. 1984, 19:261-265.
117. Magalhâes L.G., Kapadia G.J., da Silva Tonuci L.R., Caixeta S.C., Parreira N.A., Rodrigues V., Da Silva Filho A.A. In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol. Res. 2010, 106:395-401.
118. Magalhâes L.G., Machado C.B., Morais E.R., de Carvalho Moreira E.B., Soares C.S., da Silva S.H., Da Silva Filho A.A., Rodrigues V. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res. 2009, 104:1197-1201.
119. Manderson L., Aagaard-Hansen J., Allotey P., Gyapong M., Sommerfeld J. Social research on neglected diseases of poverty: continuing and emerging themes. PLoS Negl. Trop. Dis. 2009, 3:e332.
120. Manneck, T., Braissant, O., Ellis, W., Keiser, J., 2010b. Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo. Exp. Parasitol., in press. doi:10.1016/j.exppara.2010.08.011.
121. Manneck T., Haggenmüller Y., Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 2010, 137:85-98.
122. Marchal, B., Van Dormael, M., Pirard, M., Cavalli, A., Kegels, G., Polman, K., submitted. Neglected tropical disease control in health systems: the interface between programmes and general health services. Acta Trop.
123. Matthys B., Tschannen A.B., Tian-Bi N.T., Comoé H., Diabaté S., Traoré M., Vounatsou P., Raso G., Gosoniu L., Tanner M., Cissé G., N'Goran E.K., Utzinger J. Risk factors for Schistosoma mansoni and hookworm in urban farming communities in western Côte d'Ivoire. Trop. Med. Int. Health 2007, 12:709-723.
124. McManus D.P., Gray D.J., Li Y., Feng Z., Williams G.M., Stewart D., Rey-Ladino J., Ross A.G. Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. Clin. Microbiol. Rev. 2010, 23:442-466.
125. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 2008, 21:225-242.
126. Melman S.D., Steinauer M.L., Cunningham C., Kubatko L.S., Mwangi I.N., Barker Wynn N., Mutuku M.W., Karanja D.M.S., Colley D.G., Black C.L., Secor W.E., Mkoji G.M., Loker E.S. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl. Trop. Dis. 2009, 3:e504.
127. Mohamed A.A., Mahgoub H.M., Magzoub M., Gasim G.I., Eldein W.N., Ahmed Ael A., Adam I. Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:1062-1064.
128. Molyneux D.H. Combating the " other diseases" of MDG 6 changing the paradigm to achieve equity and poverty reduction?. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:509-519.
129. Molyneux D.H., Hotez P.J., Fenwick A. " Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2005, 2:e336.
130. Moran M. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Med. 2005, 2:e302.
131. Moran M., Guzman J., Ropars A.L., McDonald A., Jameson N., Omune B., Ryan S., Wu L. Neglected disease research and development: how much are we really spending?. PLoS Med. 2009, 6:e30.
132. Mott K.E., Baltes R., Bambagha J., Baldassini B. Field studies of a reusable polyamide filter for detection of Schistosoma haematobium eggs by urine filtration. Tropenmed. Parasitol. 1982, 33:227-228.
133. Murray C.J.L., Lopez A.D. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020 1996, Harvard University Press, Harvard.
134. Murray C.J.L., Lopez A.D., Black R., Mathers C.D., Shibuya K., Ezzati M., Salomon J.A., Michaud C.M., Walker N., Vos T. Global burden of disease 2005: call for collaborators. Lancet 2007, 370:109-110.
135. Muth S., Sayasone S., Odermatt-Biays S., Phompida S., Duong S., Odermatt P. Schistosoma mekongi in Cambodia and Lao People's Democratic Republic. Adv. Parasitol. 2010, 72:179-203.
136. Neves J.K., Botelho S.P., de Melo C.M., Pereira V.R., de Lima M.C.A., Pitta I.R., Albuquerque M.C., Galdino S.L. Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni. Parasitol. Res. 2010, 107:531-538.
137. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1:153-161.
138. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
139. Obeng B.B., Aryeetey Y.A., de Dood C.J., Amoah A.S., Larbi I.A., Deelder A.M., Yazdanbakhsh M., Hartgers F.C., Boakye D.A., Verweij J.J., van Dam G.J., van Lieshout L. Application of a circulating-cathodic-antigen (CCA) strip test and real-time PCR, in comparison with microscopy, for the detection of Schistosoma haematobium in urine samples from Ghana. Ann. Trop. Med. Parasitol. 2008, 102:625-633.
140. Obonyo C.O., Muok E.M.O., Mwinzi P.N.M. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect. Dis. 2010, 10:603-611.
141. Parker M., Allen T., Hastings J. Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda. J. Biosoc. Sci. 2008, 40:161-181.
142. Payne L., Fitchett J.R. Bringing neglected tropical diseases into the spotlight. Trends Parasitol. 2010, 26:421-423.
143. Peeling R.W., Smith P.G., Bossuyt P.M. A guide for diagnostic evaluations. Nat. Rev. Microbiol. 2006, 4(9 Suppl.):S2-6.
144. Pitta M.G., Silva A.C., Neves J.K., Silva P.G., Irmao J.I., Malagueno E., Santana J.V., Lima M.C., Galdino S.L., Pitta I.R., Albuquerque M.C. New imidazolidinic bioisosters: potential candidates for antischistosomal drugs. Mem. Inst. Oswaldo Cruz 2006, 101(Suppl. 1):313-316.
145. Plouvier S., Leroy J.-C., Colette J. A propos d'une technique simple de filtration des urines dans le diagnostic de la bilharziose urinaire en enquête de masse. Med. Trop. 1975, 35:229-230.
146. Pontes L.A., Dias-Neto E., Rabello A. Detection by polymerase chain reaction of Schistosoma mansoni DNA in human serum and feces. Am. J. Trop. Med. Hyg. 2002, 66:157-162.
147. Pontes L.A., Oliveira M.C., Katz N., Dias-Neto E., Rabello A. Comparison of a polymerase chain reaction and the Kato-Katz technique for diagnosing infection with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 2003, 68:652-656.
148. Raso G., Vounatsou P., Singer B.H., N'Goran E.K., Tanner M., Utzinger J. An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6934-6939.
149. Ribeiro-dos-Santos G., Verjovski-Almeida S., Leite L.C. Schistosomiasis-a century searching for chemotherapeutic drugs. Parasitol. Res. 2006, 99:505-521.
150. Ridley R.G. Diagnostics take centre stage. Nat. Rev. Microbiol. 2006, 4(9 Suppl.):S1.
151. Rollinson D. A wake up call for urinary schistosomiasis: reconciling research effort with public health importance. Parasitology 2009, 136:1593-1610.
152. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol. 1986, 61:294-303.
153. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 2008, 14:407-412.
154. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009, 460:345-351. Schistosoma japonicum Genome Sequencing Functional Analysis Consortium.
155. Silué K.D., Raso G., Yapi A., Vounatsou P., Tanner M., N'Goran E.K., Utzinger J. Spatially-explicit risk profiling of Plasmodium falciparum infections at a small scale: a geostatistical modelling approach. Malar. J. 2008, 7:111.
156. Simoonga C., Utzinger J., Brooker S., Vounatsou P., Appleton C.C., Stensgaard A.S., Olsen A., Kristensen T.K. Remote sensing, geographical information system and spatial analysis for schistosomiasis epidemiology and ecology in Africa. Parasitology 2009, 136:1683-1693.
157. Singer B.H., Castro M.C. Bridges to sustainable tropical health. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16038-16043.
158. Sissoko M.S., Dabo A., Traore H., Diallo M., Traore B., Konate D., Niare B., Diakite M., Kamate B., Traore A., Bathily A., Tapily A., Toure O.B., Cauwenbergh S., Jansen H.F., Doumbo O.K. Efficacy of artesunate+sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One 2009, 4:e6732.
159. Smits H.L. Prospects for the control of neglected tropical diseases by mass drug administration. Expert Rev. Anti Infect. Ther. 2009, 7:37-56.
160. Southgate V.R. Schistosomiasis in the Senegal River Basin: before and after the construction of the dams at Diama, Senegal and Manantali, Mali and future prospects. J. Helminthol. 1997, 71:125-132.
161. Speich B., Knopp S., Mohammed K.A., Khamis I.S., Rinaldi L., Cringoli G., Rollinson D., Utzinger J. Comparative cost assessment of the Kato-Katz and FLOTAC techniques for soil-transmitted helminth diagnosis in epidemiological surveys. Parasit. Vectors 2010, 3:71.
162. Spiegel J.M., Dharamsi S., Wasan K.M., Yassi A., Singer B., Hotez P.J., Hanson C., Bundy D.A.P. Which new approaches to tackling neglected tropical diseases show promise?. PLoS Med. 2010, 7:e1000255.
163. Standley C.J., Adriko M., Arinaitwe M., Atuhaire A., Kazibwe F., Fenwick A., Kabatereine N.B., Stothard J.R. Epidemiology and control of intestinal schistosomiasis on the Sesse Islands, Uganda: integrating malacology and parasitology to tailor local treatment recommendations. Parasit. Vectors 2010, 3:64.
164. Standley C.J., Lwambo N.J.S., Lange C.N., Kariuki H.C., Adriko M., Stothard J.R. Performance of circulating cathodic antigen (CCA) urine-dipsticks for rapid detection of intestinal schistosomiasis in schoolchildren from shoreline communities of Lake Victoria. Parasit. Vectors 2010, 3:7.
165. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 2006, 6:411-425.
166. Stensgaard A.S., Saarnak C.F.L., Utzinger J., Vounatsou P., Simoonga C., Mushinge G., Rahbek C., Mohlenberg F., Kristensen T.K. Virtual globes and geospatial health: the potential of new tools in the management and control of vector-borne diseases. Geospat. Health 2009, 3:127-141.
167. Stiles C.W. Early history, in part esoteric, of the hookworm (uncinariasis) campaign in our southern United States. J. Parasitol. 1939, 25:283-308.
168. Stoll N.R. This wormy world. J. Parasitol. 1947, 33:1-18.
169. Stothard J.R. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:325-332.
170. Stothard J.R., Chitsulo L., Kristensen T.K., Utzinger J. Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges. Parasitology 2009, 136:1665-1675.
171. Stothard J.R., Kabatereine N.B., Tukahebwa E.M., Kazibwe F., Rollinson D., Mathieson W., Webster J.P., Fenwick A. Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop. 2006, 97:219-228.
172. Stothard J.R., Sousa-Figueiredo J.C., Standley C., Van Dam G.J., Knopp S., Utzinger J., Ameri H., Khamis A.N., Khamis I.S., Deelder A.M., Mohammed K.A., Rollinson D. An evaluation of urine-CCA strip test and fingerprick blood SEA-ELISA for detection of urinary schistosomiasis in schoolchildren in Zanzibar. Acta Trop. 2009, 111:64-70.
173. Sweet W.C., Cort W.W., Schapiro L., Stoll N.R., Riley W.A. A study of the effect of treatment and sanitation on the level of hookworm infestation in certain areas in Panama. Am. J. Hyg. Monograph Series No. 9 1929, 98-138.
174. Tanaka H., Tsuji M. From discovery to eradication of schistosomiasis in Japan: 1847-1996. Int. J. Parasitol. 1997, 27:1465-1480.
175. Tchuem Tchuenté, L.A., 2010. Control of soil-transmitted helminths in sub-Saharan Africa: diagnosis, drug efficacy concerns and challenges. Acta Trop., PMID: 20654570.
176. Tchuem Tchuenté L.A., Southgate V.R., Jourdane J., Webster B.L., Vercruysse J. Schistosoma intercalatum: an endangered species in Cameroon?. Trends Parasitol. 2003, 19:389-393.
177. ten Hove R.J., Verweij J.J., Vereecken K., Polman K., Dieye L., van Lieshout L. Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S. haematobium infection in stool samples collected in northern Senegal. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:179-185.
178. UN, 2010. World Urbanization Prospects: The 2009 Revision. United Nations, <> (accessed 24.04.10). http://esa.un.org/unpd/wup/index.htm.
179. Utzinger J., Bergquist R., Olveda R., Zhou X.N. Important helminth infections in Southeast Asia: diversity, potential for control and prospects for elimination. Adv. Parasitol. 2010, 72:1-30.
180. Utzinger J., Bergquist R., Xiao S.H., Singer B.H., Tanner M. Sustainable schistosomiasis control-the way forward. Lancet 2003, 362:1932-1934.
181. Utzinger J., Booth M., N'Goran E.K., Müller I., Tanner M., Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 2001, 122:537-544.
182. Utzinger J., de Savigny D. Control of neglected tropical diseases: integrated chemotherapy and beyond. PLoS Med. 2006, 3:e112.
183. Utzinger J., Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 2004, 5:263-285.
184. Utzinger J., N'Goran E.K., Esse Aya C.M., Acka Adjoua C., Lohourignon K.L., Tanner M., Lengeler C. Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire. Trop. Med. Int. Health 1998, 3:711-720.
185. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop. Med. Int. Health 2000, 5:771-778.
186. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., Xiao S.H., Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 2000, 355:1320-1325.
187. Utzinger J., Raso G., Brooker S., de Savigny D., Tanner M., Ornbjerg N., Singer B.H., N'Goran E.K. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009, 136:1859-1874.
188. Utzinger J., Rinaldi L., Lohourignon L.K., Rohner F., Zimmermann M.B., Tschannen A.B., N'Goran E.K., Cringoli G. FLOTAC: a new sensitive technique for the diagnosis of hookworm infections in humans. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:84-90.
189. Utzinger J., Tanner M., Keiser J. ACTs for schistosomiasis: do they act?. Lancet Infect. Dis. 2010, 10:579-581.
190. Utzinger J., Xiao S.H., Tanner M., Keiser J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs 2007, 8:105-116.
191. Utzinger J., Zhou X.N., Chen M.G., Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop. 2005, 96:69-96.
192. van Dam G.J., Wichers J.H., Falcao Ferreira T.M., Ghati D., van Amerongen A., Deelder A.M. Diagnosis of schistosomiasis by reagent strip test for detection of circulating cathodic antigen. J. Clin. Microbiol. 2004, 42:5458-5461.
193. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W.N., Nagelkerke N.J.D., Habbema J.D.F., Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003, 86:125-139.
194. van Lieshout L., Polderman A.M., Deelder A.M. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop. 2000, 77:69-80.
195. van Nassauw L., Toovey S., Van Op den Bosch J., Timmermans J.P., Vercruysse J. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Med. Infect. Dis. 2008, 6:253-258.
196. Wang L., Utzinger J., Zhou X.N. Schistosomiasis control: experiences and lessons from China. Lancet 2008, 372:1793-1795.
197. Wang L.D., Chen H.G., Guo J.G., Zeng X.J., Hong X.L., Xiong J.J., Wu X.H., Wang X.H., Wang L.Y., Xia G., Hao Y., Chin D.P., Zhou X.N. A strategy to control transmission of Schistosoma japonicum in China. N. Engl. J. Med. 2009, 360:121-128.
198. Wang L.D., Guo J.G., Wu X.H., Chen H.G., Wang T.P., Zhu S.P., Zhang Z.H., Steinmann P., Yang G.J., Wang S.P., Wu Z.D., Wang L.Y., Hao Y., Bergquist R., Utzinger J., Zhou X.N. China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Trop. Med. Int. Health 2009, 14:1475-1483.
199. Wang Y.L., Holmes E., Nicholson J.K., Cloarec O., Chollet J., Tanner M., Singer B.H., Utzinger J. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:12676-12681.
200. Wang Y.L., Li J.V., Saric J., Keiser J., Wu J.F., Utzinger J., Holmes E. Advances in metabolic profiling of experimental nematode and trematode infections. Adv. Parasitol. 2010, 73:373-404.
201. Wang Y.L., Utzinger J., Xiao S.H., Xue J., Nicholson J.K., Tanner M., Singer B.H., Holmes E. System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster. Mol. Biochem. Parasitol. 2006, 146:1-9.
202. Webster J.P., Oliviera G., Rollinson D., Gower C.M. Schistosome genomes: a wealth of information. Trends Parasitol. 2010, 26:103-106.
203. Weinberg E.D., Moon J. Malaria and iron: history and review. Drug Metab. Rev. 2009, 41:644-662.
204. Weiss M.G. Stigma and the social burden of neglected tropical diseases. PLoS Negl. Trop. Dis. 2008, 2:e237.
205. White N.J. Qinghaosu (artemisinin): the price of success. Science 2008, 320:330-334.
206. Whitlock H.V. Some modifications of the McMaster helminth egg-counting technique and apparatus. J. Counc. Sci. Ind. Res. 1948, 21:177-180.
207. WHO, 1985. The control of schistosomiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. 728, 1-114.
208. WHO The World Health Report 1999. Making a Difference 1999, World Health Organization, Geneva.
209. WHO The World Health Report 2000. Health Systems: Improving Performance 2000, World Health Organization, Geneva.
210. WHO The World Health Report 2001. Mental Health: New Understanding, New Hope 2001, World Health Organization, Geneva.
211. WHO Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. 912 2002, 1-57.
212. WHO The World Health Report 2002. Reducing Risks, Promoting Healthy Life 2002, World Health Organization, Geneva.
213. WHO The World Health Report 2003. Shaping the Future 2003, World Health Organization, Geneva.
214. WHO Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers 2006, World Health Organization, Geneva.
215. Woolhouse M.E.J. Patterns in parasite epidemiology: the peak shift. Parasitol. Today 1998, 14:428-434.
216. Wu J.F., Holmes E., Xue J., Xiao S.H., Singer B.H., Tang H.R., Utzinger J., Wang Y.L. Metabolic alterations in the hamster co-infected with Schistosoma japonicum and Necator americanus. Int. J. Parasitol. 2010, 40:695-703.
217. Xiao S.H., Keiser J., Chen M.G., Tanner M., Utzinger J. Research and development of antischistosomal drugs in the People's Republic of China: a 60-year review. Adv. Parasitol. 2010, 73:231-295.
218. Xiao S.H., Keiser J., Chollet J., Utzinger J., Dong Y., Endriss Y., Vennerstrom J.L., Tanner M. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob. Agents Chemother. 2007, 51:1440-1445.
219. Xiao S.H., Mei J.Y., Jiao P.Y. The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol. Res. 2009, 106:237-246.
220. Yang G.J., Utzinger J., Lv S., Qian Y.J., Li S.Z., Wang Q., Bergquist R., Vounatsou P., Li W., Yang K., Zhou X.N. The regional network for Asian Schistosomiasis and Other Helminth Zoonoses (RNAS+): target diseases in face of climate change. Adv. Parasitol. 2010, 73:101-135.
221. Yang G.J., Vounatsou P., Zhou X.N., Tanner M., Utzinger J. A potential impact of climate change and water resource development on the transmission of Schistosoma japonicum in China. Parassitologia 2005, 47:127-134.
222. Yousif F., Hifnawy M.S., Soliman G., Boulos L., Labib T., Mahmoud S., Ramzy F., Yousif M., Hassan I., Mahmoud K., El-Hallouty S.M., El-Gendy M., Gohar L., El-Manawaty M., Fayyad W., El-Menshawi B.S. Large-scale in vitro screening of Egyptian native and cultivated plants for schistosomicidal activity. Pharm. Biol. 2007, 45:501-510.
223. Yu J.M., de Vlas S.J., Jiang Q.W., Gryseels B. Comparison of the Kato-Katz technique, hatching test and indirect hemagglutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China. Parasitol. Int. 2007, 56:45-49.
224. Zhou X.N., Guo J.G., Wu X.H., Jiang Q.W., Zheng J., Dang H., Wang X.H., Xu J., Zhu H.Q., Wu G.L., Li Y.S., Xu X.J., Chen H.G., Wang T.P., Zhu Y.C., Qiu D.C., Dong X.Q., Zhao G.M., Zhang S.J., Zhao N.Q., Xia G., Wang L.Y., Zhang S.Q., Lin D.D., Chen M.G., Hao Y. Epidemiology of schistosomiasis in the People's Republic of China, 2004. Emerg. Infect. Dis. 2007, 13:1470-1476.
225. Zhou X.N., Yang G.J., Yang K., Wang X.H., Hong Q.B., Sun L.P., Malone J.B., Kristensen T.K., Bergquist N.R., Utzinger J. Potential impact of climate change on schistosomiasis transmission in China. Am. J. Trop. Med. Hyg. 2008, 78:188-194.
226. Zhu Y.C. Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop. 2005, 96:130-136.